Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tesetaxel Second-line in Advanced Gastric Cancer
NCT01095120Phase 2Unknown
- Sponsor
- Genta Incorporated
- Start
- Mar 2010
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tesetaxel in gastric adenocarcinoma, esophagogastric junction adenocarcinoma (GEJA), sponsored by Genta Incorporated. Status: unknown.
02
Drugs
tesetaxel
03
Conditions
gastric adenocarcinomaesophagogastric junction adenocarcinoma (GEJA)
Beyond the preview
Go deeper on NCT01095120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01095120.